Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/03/2026 | Q4 | $1.2B | -- | -- | $0.89 | -- |
| 11/13/2025 | Q3 | $1.2B | $1.6B | $0.95 | $1.09 | -$0.14 |
| 08/13/2025 | Q2 | $1.2B | $1.4B | $0.86 | $0.99 | -$0.13 |
| 05/14/2025 | Q1 | $1.1B | $1.3B | $0.61 | $0.80 | -$0.19 |
| 02/25/2025 | Q4 | $1B | $1.4B | $0.61 | $0.70 | -$0.09 |
| 11/07/2024 | Q3 | $1.1B | $1.4B | $0.66 | $0.89 | -$0.23 |
| 08/07/2024 | Q2 | $1.1B | $1.4B | $0.53 | $0.81 | -$0.27 |
| 05/08/2024 | Q1 | $988.5M | $1.3B | $0.50 | $0.62 | -$0.12 |
| 02/28/2024 | Q4 | $907.3M | $1.2B | $0.46 | $0.64 | -$0.17 |
| 11/09/2023 | Q3 | -- | $1.3B | $0.68 | -- | -- |
| 06/30/2023 | Q2 | -- | $1.2B | $0.59 | -- | -- |
| 03/31/2023 | Q1 | -- | $1.1B | $0.43 | -- | -- |
| 12/31/2022 | Q4 | -- | $1.1B | $0.49 | -- | -- |
| 09/30/2022 | Q3 | -- | $1.1B | $0.47 | -- | -- |
| 06/30/2022 | Q2 | -- | $1.1B | $0.43 | -- | -- |
| 03/31/2022 | Q1 | -- | $1B | $0.32 | -- | -- |
| 12/31/2021 | Q4 | -- | $940.3M | $0.12 | -- | -- |
| 09/30/2021 | Q3 | -- | $927.2M | $0.50 | -- | -- |
| 06/30/2021 | Q2 | -- | $923.6M | $0.46 | -- | -- |
| 03/31/2021 | Q1 | -- | $860.2M | $0.36 | -- | -- |
| 12/31/2020 | Q4 | -- | $864.2M | $0.11 | -- | -- |
| 09/30/2020 | Q3 | -- | $884M | $0.41 | -- | -- |
| 06/30/2020 | Q2 | -- | $870.2M | $0.34 | -- | -- |
| 03/31/2020 | Q1 | -- | $907.4M | $0.26 | -- | -- |
| 12/31/2019 | Q4 | -- | $916.8M | $0.28 | -- | -- |
| 09/30/2019 | Q3 | -- | $940.1M | $0.39 | -- | -- |
| 06/30/2019 | Q2 | -- | $914.9M | $0.33 | -- | -- |
| 03/31/2019 | Q1 | -- | $866.2M | $0.30 | -- | -- |
| 12/31/2018 | Q4 | -- | $211.5M | $0.01 | -- | -- |
| 09/30/2018 | Q3 | -- | $831.4M | -$0.12 | -- | -- |
| 06/30/2018 | Q2 | -- | $845.8M | $0.27 | -- | -- |
| 03/31/2018 | Q1 | -- | $807.5M | $0.25 | -- | -- |
| 12/31/2017 | Q4 | -- | $980.1M | $0.08 | -- | -- |
| 09/30/2017 | Q3 | -- | $1B | $0.32 | -- | -- |
| 06/30/2017 | Q2 | -- | $980.6M | $0.63 | -- | -- |
| 03/31/2017 | Q1 | -- | $964.3M | -$0.39 | -- | -- |
| 12/31/2016 | Q4 | -- | $614.7M | $0.19 | -- | -- |
| 09/30/2016 | Q3 | -- | $963.9M | $0.33 | -- | -- |
| 06/30/2016 | Q2 | -- | $811.9M | $0.16 | -- | -- |
| 03/31/2016 | Q1 | -- | $549.9M | $0.23 | -- | -- |
| 12/31/2015 | Q4 | -- | $532.1M | $0.20 | -- | -- |
Stantec, Inc. reported $1.6B worth of top line sales in its most recent quarter.
Stantec, Inc. announced earnings per share of $0.95 which represents a miss of analyst forecast a $1.09 per share.
Stantec, Inc. reported $608.4M that represents $5.33 per share over the last quarter.
Stantec, Inc.'s earnings are forecast to grow from $2.31 per share to $3.05 per share next year representing an increase of 65.04%.
Stantec, Inc.'s next earnings date is March 3, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.